Showing results (2551-2560 of 3,476) with videos related to

Sort By:
Pageof 348
Journal of Natural Products|April 18, 2009
Lactones from Angiopteris caudatiformisYong-Ming Yu, Jun-Shan Yang, Chao-Zhong Peng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 29, 2005
[Flow cytometry-pathology combined study of breast cancer]Zhi-yong Yu, Jin-ming Yu, Tai-huang Wu, et al.
Cellular & Molecular Immunology|March 6, 2008
Characterization of a novel anti-DR5 monoclonal antibody WD1 with the potential to induce tumor cell apoptosisJing Wang, Zhou Lin, Chun Xia Qiao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
C-Reactive Protein: The Most Familiar StrangerShang-Rong Ji, Shu-Hao Zhang, Yue Chang, et al.
Molecular Immunology|September 5, 2012
Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodiesNien-Yi Chen, Alfur Fu-Hsin Hung, Chien-Jen Lin, et al.
Journal of Advanced Research|September 12, 2025
SAMHD1 promotes cardiac repair post myocardial infarction by targeting NR4a1 to regulate macrophage metabolic reprogrammingYu-Lan Ma, Hai-Yang Ni, Zhen Guo, et al.
In Vivo (Athens, Greece)|June 27, 2024
Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck CancerMing-Yu Chou, Wen-Chi Wu, Pen-Yuan Chu, et al.
Genesis (New York, N.Y. : 2000)|August 11, 2016
Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13Ming Yu, Salma Al-Dallal, Latifa Al-Haj, et al.
Acta Pharmacologica Sinica|November 24, 2015
Preclinical pharmacokinetics of TPN729MA, a novel PDE5 inhibitor, and prediction of its human pharmacokinetics using a PBPK modelZhi-wei Gao, Yun-ting Zhu, Ming-ming Yu, et al.
Pageof 348